3M™ Littmann® Stethoscopes and Eko Announce New Collaboration
October 19 2020 - 10:07AM
Business Wire
Bringing together science, technology,
and comprehensive solutions to redefine what’s possible in
healthcare
As the world of healthcare and its dependence on auscultation
continues to evolve, digital technology is being introduced to meet
the advancing demands of the industry. To meet these changing
needs, 3M™ Littmann® Stethoscopes and Eko are announcing a new
collaboration that will marry best-in-class 3M Littmann stethoscope
technology with advanced Eko digital innovations.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20201019005547/en/
The new 3M™ Littmann® CORE Digital
Stethoscope connects to Eko software to allow clinicians to
visualize, save, and share sounds at the touch of a button. (Image
Credit: Eko)
The new 3M Littmann CORE Digital Stethoscope offers clinicians
access to both analog and digital auscultation options and connects
to Eko’s software and AI algorithms1 to help clinicians better
interpret sounds and detect heart murmurs. Benefits to clinicians
include:
- Helps increase confidence in auscultation assessments
- Amplification2 and active noise cancellation
- Visualization of sound data during auscultation
- Access to Eko’s AI and clinical decision support, helping
providers to screen for heart murmurs during routine physical
exams
- Access to Eko’s telemedicine software, making these benefits
available for both in-person and remote patient care
“Today, 3M Littmann Stethoscopes embarks upon a new era in our
long history as a pioneer in auscultation innovation and quality by
introducing our most advanced stethoscope yet,” said Kristi
Barnett, Sr. Director, 3M Medical Devices. “The new 3M Littmann
CORE Digital Stethoscope combines the superior acoustics of the
Littmann Cardiology IV Stethoscope with Eko's digital technology
and software to aid and enhance a clinician’s auscultation
assessments.”
The collaboration between 3M Littmann Stethoscopes and Eko
brings together two innovative companies that are focused on
delivering comprehensive health care solutions that drive better
patient outcomes.
“This combination is a gamechanger – allowing a physician in
rural America or a nurse treating patients in a non-office setting
to have access to cutting-edge clinical decision support.”
In January of this year, Eko received FDA clearance for an
algorithm that can detect the presence of suspected heart murmurs.
The 3M Littmann CORE Digital Stethoscope can connect to Eko
software, including its heart murmur AI1 and its telemedicine
software, enabling enhanced in-person or remote patient care.
“For clinicians, listening is a gateway to making critical
diagnoses. Being able to confidently assess heart and lung sounds
helps ensure the best cardiac and pulmonary care possible,” said
Connor Landgraf, co-founder and CEO, Eko. “Partnering with 3M
Littmann Stethoscopes allows us to incorporate the power of our
digital and machine learning technology alongside the stethoscope
trusted by millions of clinicians worldwide, which can help impact
patient outcomes and quality of care. Combining the 3M Littmann
CORE Digital Stethoscope with the Eko platform of software and AI
helps clinicians elevate cardiopulmonary care to a whole new
level.”
For more information on the 3M Littmann CORE Stethoscope or
where to buy, please visit: Littmann.com/BuyCORE. For more on Eko
software and AI, please visit ekohealth.com/platform.
1Subscription required. Eko Analysis
Software is currently available only in the U.S. Learn more at
ekohealth.com/platform
2Up to 40x amplification based on
comparison of analog versus electronically assisted amplified
listening with maximum volume at the peak frequency (125 Hz).
About 3M™ Littmann® Stethoscopes 3M™ Littmann®
Stethoscopes is a global leader in auscultation technology -
providing innovative solutions to improve patient care. Littmann
stethoscopes are trusted worldwide for precision, acoustic
excellence, reliable design and exceptional performance, helping
clinicians detect difficult-to-hear body sounds and improve patient
outcomes.
About 3M At 3M, we apply science in collaborative ways
that improve lives daily. With $32 billion in sales, our 96,000
employees connect with customers all around the world. Learn more
about 3M’s creative solutions to the world’s problems at www.3M.com
or on Twitter @3M or @3MNews.
About Eko Eko is elevating the way clinicians detect and
monitor cardiac and respiratory disease by bringing together
advanced sensors, patient and provider software, and AI-powered
analysis. Its FDA-cleared platform is used by tens of thousands of
clinicians treating millions of patients around the world,
in-person, and through telehealth. The company is headquartered in
Oakland, California and privately held, with investments from ARTIS
Ventures, NTT Venture Capital, DigiTx Ventures, Mayo Clinic, Sutter
Health, and others. For more information visit
www.ekohealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201019005547/en/
3M Taylor Johnson tjohnson9.cw@mmm.com (763) 219-3816
Eko Saige Smith eko@highwirepr.com (262) 289-7065
3M (NYSE:MMM)
Historical Stock Chart
From Mar 2024 to Apr 2024
3M (NYSE:MMM)
Historical Stock Chart
From Apr 2023 to Apr 2024